SecBot SecBot

LGNZZ

LIGAND PHARMACEUTICALS INC
OTC· Pharmaceutical Preparations· Inc. DE· CIK 0000886163 Biotech & Drug Discovery
—
Short interest
153
0.0%
Days to cover
9.0
at average volume
Filing reports
1
analyzed by SecBot
SecBot read MIXED 1 report · latest
Balance 0 bearish · 0 bullish · 1 neutral oldest → newest, height = score
Avg score ·High conf. 1/1
Strongest NEUTRAL Ligand Pharmaceuticals Inc. has filed a definitive proxy statement (DEFA14A) for its upcoming annual…
All reports →

Price

Daily candles with volume.

Signal stack

Where each data set points today.

  • Short sellersSTEADY

    Short interest 0.0% to 153 shares. 9.0 days to cover.

Recent activity
The latest filings, insider trades, analyst actions, press and options flow — newest first.
Apr 21, 2026 SEC
Ligand Pharmaceuticals Inc. has filed a definitive proxy statement (DEFA14A) for its upcoming annual shareholder…
DEFA14A — Impact 2/10

Earnings setup

Estimates
PeriodEPS est.Range30D rev.Revenue
Current Q———$77.2M
Next Q———$96.6M
Current FY———$288.9M
Next FY🔒 Fresh data, subscribers only

Short side

FINRA· Jul 31, 2026
153
shares short
0.0%
vs prior settlement
9.0
days to cover

SecBot reports

1 filing · 0 bullish · 0 bearish · 1 neutral
All LGNZZ filing & press-release reports (1)